Patents by Inventor Haiying Wang

Haiying Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10348886
    Abstract: A method of answering an incoming call on a dual-screen mobile device comprising a main body, and two screens and two sound openings which are respectively located on two opposite surfaces of the main body is provided. The method includes: upon receiving an incoming call, an incoming call operation option is displayed on a first screen of the dual-screen mobile, an answer option is determined based on an answer operation which is performed by a user in response to the incoming call operation option, where the answer option includes answering on a second screen opposite to the first screen, and a sound of the incoming call is output from the sound opening on the surface where the second screen is located in response to that the answer option indicates answering on the second screen.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: July 9, 2019
    Assignees: Hisense Mobile Communications Technology Co., Ltd., HISENSE USA CORP., Hisense International Co., Ltd.
    Inventors: Yanyan Yin, Haiying Wang
  • Patent number: 10317619
    Abstract: A high-bandwidth bend-insensitive multimode optical fiber includes a core and a cladding. A refractive index profile of the core has a parabola shape and a distribution index thereof is ?. The core has a radius of 23-27 ?m. A maximum relative refractive index difference of a central position of the core is 0.9%-1.2%. The core is a germanium-fluorine co-doped silicon dioxide glass layer. The central position of the core has a minimum amount of fluorine doped, and a mass percentage of fluorine content is CF,min. A mass percentage of fluorine content of the core changes with the radius according to a function. The cladding successively comprises an inner cladding, a trench cladding, and an outer cladding from inside to outside. The optical fiber reduces bandwidth-wavelength sensitivity while improving bandwidth performance; is compatible with existing OM3/OM4 multimode optical fibers, and support wavelength-division multiplexing technology in a wavelength range of 850-950 nm.
    Type: Grant
    Filed: October 9, 2016
    Date of Patent: June 11, 2019
    Assignee: YANGTZE OPTICAL FIBRE AND CABLE JOINT STOCK LIMITED COMPANY
    Inventors: Runhan Wang, Rong Huang, Haiying Wang, Ruichun Wang, Shengya Long
  • Publication number: 20180372946
    Abstract: A high-bandwidth bend-insensitive multimode optical fiber includes a core and a cladding. A refractive index profile of the core has a parabola shape and a distribution index thereof is ?. The core has a radius of 23-27 ?m. A maximum relative refractive index difference of a central position of the core is 0.9%-1.2%. The core is a germanium-fluorine co-doped silicon dioxide glass layer. The central position of the core has a minimum amount of fluorine doped, and a mass percentage of fluorine content is CF,min. A mass percentage of fluorine content of the core changes with the radius according to a function. The cladding successively comprises an inner cladding, a trench cladding, and an outer cladding from inside to outside. The optical fiber reduces bandwidth-wavelength sensitivity while improving bandwidth performance; is compatible with existing OM3/OM4 multimode optical fibers, and support wavelength-division multiplexing technology in a wavelength range of 850-950 nm.
    Type: Application
    Filed: October 9, 2016
    Publication date: December 27, 2018
    Inventors: Runhan WANG, Rong HUANG, Haiying WANG, Ruichun WANG, Shengya LONG
  • Publication number: 20180291456
    Abstract: Compositions, systems and methods for the diagnosing the risk of acute myocardial infarction are provided. The methods described herein relate to the use of biomarkers, such as gene expression profiles, and analytical tools for providing information to a health care provider or the patient, that is relevant to the cardiovascular health of the patient.
    Type: Application
    Filed: June 13, 2018
    Publication date: October 11, 2018
    Inventors: Eric J. TOPOL, Evan MUSE, Mark CONNELLY, Timothy JATKOE, Haiying WANG
  • Publication number: 20180288220
    Abstract: A method of answering an incoming call on a dual-screen mobile device comprising a main body, and two screens and two sound openings which are respectively located on two opposite surfaces of the main body is provided. The method includes: upon receiving an incoming call, an incoming call operation option is displayed on a first screen of the dual-screen mobile, an answer option is determined based on an answer operation which is performed by a user in response to the incoming call operation option, where the answer option includes answering on a second screen opposite to the first screen, and a sound of the incoming call is output from the sound opening on the surface where the second screen is located in response to that the answer option indicates answering on the second screen.
    Type: Application
    Filed: March 26, 2018
    Publication date: October 4, 2018
    Applicants: Hisense Mobile Communications Technology Co., Ltd., Hisense USA Corp., Hisense International Co., Ltd.
    Inventors: Yanyan Yin, Haiying Wang
  • Patent number: 10041120
    Abstract: Compositions, systems and methods for the diagnosing the risk of acute myocardial infarction are provided. The methods described herein relate to the use of biomarkers, such as gene expression profiles, and analytical tools for providing information to a health care provider or the patient, that is relevant to the cardiovascular health of the patient.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: August 7, 2018
    Assignees: SCRIPPS HEALTH, ORTHO-CLINICAL DIAGNOSTICS, INC.
    Inventors: Eric J. Topol, Evan Muse, Mark Connelly, Timothy Jatkoe, Haiying Wang
  • Patent number: 9862842
    Abstract: In an embodiment, a method for making an infrared radiation absorbing coating mixture comprises: forming an ITO coating mixture comprising ITO and a first coating matrix, wherein the first coating matrix comprises the partial condensate of a silanol, wherein the ITO coating mixture is free of colloidal silica; forming a colloidal silica coating mixture comprising colloidal silica and a second coating matrix, wherein the second coating matrix comprises the partial condensate of a silanol; and mixing the ITO coating mixture with the colloidal silica coating mixture to form a combined mixture. The combined mixture does not comprise a precipitate visible to the unaided eye after 2 weeks without stirring.
    Type: Grant
    Filed: November 20, 2012
    Date of Patent: January 9, 2018
    Assignee: SABIC GLOBAL TECHNOLOGIES B.V.
    Inventors: Liping Zheng, Steven M. Gasworth, James E. Pickett, Haiying Wang, Zhen Liu, Qijia Fu, Yang Dong, Hongxia Xi
  • Patent number: 9493755
    Abstract: The present invention provides a bacillus sp. having a deposit access number of CGMCC NO. 5744 and a hyaluronidase produced by the bacillus and the amino acid sequence of the hyaluronidase is shown in SEQ ID NO: 2. The present invention further relates to a process for preparing oligomeric hyaluronic acid or salts thereof or low-molecular-weight hyaluronic acid or salts thereof by using the bacillus or the hyaluronidase produced thereby. The produced oligomeric hyaluronates or low-molecular-weight hyaluronates have advantages such as good transdermal absorption ability, high purity, no cytotoxicity, potent antioxidant ability. The present invention also provides use of the bacillus having a deposit access number of CGMCC NO. 5744, or the hyaluronidase, oligomeric hyaluronates or salts thereof, low-molecular-weight hyaluronates or salts thereof produced by the bacillus in the fields of osmetics, food products and medicines.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: November 15, 2016
    Assignee: BLOOMAGE FREDA BIOPHARM CO., LTD.
    Inventors: Xueping Guo, Yanli Shi, Liping Qiao, Ning Feng, Guanfeng Wang, Haina Li, Wei Xue, Haiying Wang, Yihong Luan, Aihua Liu
  • Publication number: 20160130641
    Abstract: The disclosed edge-blocker oligonucleotide based AS-NEPB-PCR method amplifies allele specific DNA (or RNA) while dramatically blocking amplification of wild type (WT) DNA (or RNA). The AS-NEPB-PCR design allows ready modification of an existing PCR reaction setup with an edge-blocker oligonucleotide together with an allele specific primer complementary to the mutant sequence to achieve allele specific amplification. The method simplifies assay optimization procedures and achieved sensitivity sufficient to detect a signal present at 0.1% level with close to 100% specificity, which is useful in detecting SNP or genetic mutations. The method was used to detect three different genetic mutations in cancer, in KRAS, BRAF, and EGFR, with three different types of modified edge-blocker oligonucleotides (phosphate, inverted dT and amino-C7). It was possible to detect one copy of mutant DNA in 1000-copy of normal DNA background of a heterogeneous sample, and was far more sensitive than the other blocking method.
    Type: Application
    Filed: February 13, 2013
    Publication date: May 12, 2016
    Inventors: Haiying Wang, Yuqiu Jiang, Yixin Wang
  • Publication number: 20160060485
    Abstract: In an embodiment, a silicone coating composition, comprises a coating matrix, comprising the partial condensate of a silanol of the formula RnSi(OH)4?n, where n equals 1 or 2, and wherein R is selected from a C1-3 alkyl radical, a vinyl radical, a 3,3,3-trifluoropropyl radical, a gamma-glycidoxypropyl radical, and a gamma-methacryloxypropyl radical; colloidal silica; and ITO having a mean particle size of less than or equal to 60 nm as determined by dynamic light scattering. In another embodiment, a coated glazing, comprises a plastic substrate; and a cured silicone coating on the substrate; wherein the coated glazing has a haze of less than or equal to 3% as measured in accordance with ASTM D1003-11, procedure A with CIE standard illuminant C.
    Type: Application
    Filed: November 11, 2015
    Publication date: March 3, 2016
    Inventors: Liping Zheng, Steven M. Gasworth, James E. Pickett, Haiying Wang, Zhen Liu, Qijia Fu, Yang Dong, Hongxia Xi
  • Publication number: 20160060469
    Abstract: In an embodiment, a silicone coating composition, comprises a coating matrix comprising a partial condensate of a silanol of the formula RnSi(OH)4-n, where n equals 1 or 2, and wherein R is selected from a C1-3 alkyl radical, a vinyl radical, a 3,3,3-trifluoropropyl radical, a gamma-glycidoxypropyl radical, and a gamma-methacryloxypropyl radical; and ITO having a mean particle size of less than or equal to 60 nm as determined by dynamic light scattering; and wherein the silicone coating composition is free of colloidal silica. In another embodiment, a coated glazing, comprises a plastic substrate; and a cured silicone coating on the substrate.
    Type: Application
    Filed: November 11, 2015
    Publication date: March 3, 2016
    Inventors: Liping Zheng, Steven M. Gasworth, James E. Pickett, Haiying Wang, Zhen Liu, Qijia Fu, Yang Dong, Hongxia Xi
  • Publication number: 20150361496
    Abstract: Compositions, systems and methods for the diagnosing the risk of acute myocardial infarction are provided. The methods described herein relate to the use of biomarkers, such as gene expression profiles, and analytical tools for providing information to a health care provider or the patient, that is relevant to the cardiovascular health of the patient.
    Type: Application
    Filed: May 15, 2015
    Publication date: December 17, 2015
    Inventors: Eric J. TOPOL, Evan MUSE, Mark CONNELLY, Timothy JATKOE, Haiying WANG
  • Publication number: 20150175991
    Abstract: The present invention provides a bacillus sp. having a deposit access number of CGMCC NO. 5744 and a hyaluronidase produced by the bacillus and the amino acid sequence of the hyaluronidase is shown in SEQ ID NO: 2. The present invention further relates to a process for preparing oligomeric hyaluronic acid or salts thereof or low-molecular-weight hyaluronic acid or salts thereof by using the bacillus or the hyaluronidase produced thereby. The produced oligomeric hyaluronates or low-molecular-weight hyaluronates have advantages such as good transdermal absorption ability, high purity, no cytotoxicity, potent antioxidant ability. The present invention also provides use of the bacillus having a deposit access number of CGMCC NO. 5744, or the hyaluronidase, oligomeric hyaluronates or salts thereof, low-molecular-weight hyaluronates or salts thereof produced by the bacillus in the fields of osmetics, food products and medicines.
    Type: Application
    Filed: November 29, 2012
    Publication date: June 25, 2015
    Inventors: Xueping Guo, Yanli Shi, Liping Qiao, Ning Feng, Guanfeng Wang, Haina Li, Wei Xue, Haiying Wang, Yihong Luan, Aihua Liu
  • Patent number: 8804467
    Abstract: The present invention provides an implementation method, implementation device for electronic alarm clock, and a mobile communication terminal thereof, the main content of which includes: determining a first time length capable of achieving the alert purpose by learning the time when a user inputs an instruction of stopping shaking and/or ringing during a plurality of shaking and/or ringing processes, and keeping, in a time period, the shaking and/or ringing intensity when the first time length is over, thus enabling the quick alert in the case which avoids frightening the user by abrupt shaking and/or ringing.
    Type: Grant
    Filed: January 25, 2011
    Date of Patent: August 12, 2014
    Assignee: Hisense Mobile Communications Technology Co., Ltd.
    Inventor: Haiying Wang
  • Publication number: 20130224476
    Abstract: In an embodiment, a method for making an infrared radiation absorbing coating comprises: forming an ITO coating mixture comprising ITO and a first coating matrix, wherein the first coating matrix comprises the partial condensate of a silanol of the formula RnSi(OH)4-n, where n equals 1 or 2, and wherein R is selected from a C1-3 alkyl radical, a vinyl radical, a 3,3,3-trifluoropropyl radical, a gamma-glycidoxypropyl radical, and a gamma-methacryloxypropyl radical, wherein the ITO coating mixture is free of colloidal silica; forming a colloidal silica coating mixture comprising colloidal silica and a second coating matrix, wherein the second coating matrix comprises the partial condensate of a silanol of the formula RnSi(OH)4-n, where n equals 1 or 2, and wherein R is selected from an alkyl radical of 1 to 3 inclusive carbon atoms, a vinyl radical, a 3,3,3-trifluoropropyl radical, a gamma-glycidoxypropyl radical, and a gamma-methacryloxypropyl radical; and mixing the ITO coating mixture with the colloidal sili
    Type: Application
    Filed: November 20, 2012
    Publication date: August 29, 2013
    Inventors: Liping Zheng, Steven M. Gasworth, James E. Pickett, Haiying Wang, Zhen Liu, Queenie Fu, Yang Dong, Hongxia Xi
  • Publication number: 20120307604
    Abstract: The present invention provides an implementation method, implementation device for electronic alarm clock, and a mobile communication terminal thereof, the main content of which includes: determining a first time length capable of achieving the alert purpose by learning the time when a user inputs an instruction of stopping shaking and/or ringing during a plurality of shaking and/or ringing processes, and keeping, in a time period, the shaking and/or ringing intensity when the first time length is over, thus enabling the quick alert in the case which avoids frightening the user by abrupt shaking and/or ringing.
    Type: Application
    Filed: January 25, 2011
    Publication date: December 6, 2012
    Applicant: HISENSE MOBILE COMMUNICATIONS TECHNOLOGY CO., LTD.
    Inventor: Haiying Wang
  • Publication number: 20120276132
    Abstract: Atoxic Clostridium difficile toxin proteins were expressed in an endotoxin-free Bacillus system top develop a vaccine to reduce incidence and severity of C. difficile infection (CDI). Immunogens evaluated as potential vaccine candidates are mutated toxin A (encoded by TcdA) and toxin B (TcdB), and a rationally designed chimeric protein containing full-length TcdB protein except that the receptor binding domain is replaced with that of TcdA (designated as cTxAB). A small deletion (97 amino acids) in the transmembrane domain was used to reduce or eliminate toxicity.
    Type: Application
    Filed: June 1, 2012
    Publication date: November 1, 2012
    Applicant: TUFTS UNIVERSITY
    Inventors: Hanping Feng, Haiying Wang, Saul Tzipori
  • Publication number: 20110009288
    Abstract: An assay for identifying early stage malignant melanocyte in biopsy tissues is provided by determining whether differential expression of a particular gene indicative of melanoma exceed a cut-off value.
    Type: Application
    Filed: July 8, 2010
    Publication date: January 13, 2011
    Inventors: Dmitri TALANTOV, John F. Palma, Tatiana Vener, Tim Jatkoe, Haiying Wang, Yixin Wang
  • Publication number: 20100105109
    Abstract: Improved processes for the amplification of target DNA sequences in the form of single or double stranded circular DNA molecules, especially those present in colony and plaque extracts, using multiple specific and/or random sequence oligonucleotide primers are disclosed. The product of this amplification is used for analysis by restriction enzyme digestion or DNA sequencing and other analyses that involve hybridization. Kits containing components for use in the method are also described. Also described are further uses of this amplified DNA in sequencing, genotyping and haplotyping, and other molecular biology applications.
    Type: Application
    Filed: March 18, 2008
    Publication date: April 29, 2010
    Applicant: GE Healthcare Bio-Sciences Corp.
    Inventors: Haiguang Xiao, John R. Nelson, Galina Chernaya, Haiying Wang, Paul Mitsis, Gyanendra Kumar, Carl F. Fuller, Yuyang Christine Cai
  • Publication number: 20100081145
    Abstract: Methods and kits for detecting prostate cancer in urine samples include detecting the methylation status of various genes.
    Type: Application
    Filed: December 1, 2009
    Publication date: April 1, 2010
    Inventors: Haiying Wang, Jonathan F. Baden, Tatiana Vener, Dondapati Chowdary, Abhijit Mazumder